Page 187 - scheppingen

Pluripotent Stem Cells Partially Mimicked Development of TSC2 Neurological Abnormalities.
Stem cell reports. 2017 Apr 11;8(4):883-93.
47. Jessberger S, Parent JM. Epilepsy and Adult Neurogenesis. Cold Spring Harbor perspectives in
biology. 2015 Nov 9;7(12).
48. Iori V, Iyer AM, Ravizza T, et al. Blockade of the IL-1R1/TLR4 pathway mediates disease-modification
therapeutic effects in a model of acquired epilepsy. Neurobiology of disease. 2017 Mar;99:12-23.
49. Jimenez-Mateos EM, Engel T, Merino-Serrais P, et al. Silencing microRNA-134 produces neuropro-
tective and prolonged seizure-suppressive effects. Nat Med. 2012 Jun 10.
50. Cai Z, Li S, Li S, et al. Antagonist Targeting microRNA-155 Protects against Lithium-Pilocarpine- Induced Status Epilepticus in C57BL/6 Mice by Activating Brain-Derived Neurotrophic Factor.
Frontiers in pharmacology. 2016;7:129.
51. Henshall DC. Manipulating MicroRNAs in Murine Models: Targeting the Multi-Targeting in Epilepsy.
Epilepsy currents. 2017 Jan-Feb;17(1):43-7.
52. Henshall DC, Hamer HM, Pasterkamp RJ, et al. MicroRNAs in epilepsy: pathophysiology and clinical
utility. Lancet Neurol. 2016 Dec;15(13):1368-76.
53. Chakraborty C, Sharma AR, Sharma G, Doss CGP, Lee SS. Therapeutic miRNA and siRNA: Moving
from Bench to Clinic as Next Generation Medicine. Molecular therapy Nucleic acids. 2017 Sep
15;8:132-43.
54. Hache M, Swoboda KJ, Sethna N, et al. Intrathecal Injections in Children With Spinal Muscular
Atrophy: Nusinersen Clinical Trial Experience. Journal of child neurology. 2016 Jun;31(7):899-906.
55. Finkel RS, Chiriboga CA, Vajsar J, et al. Treatment of infantile-onset spinal muscular atrophy with
nusinersen: a phase 2, open-label, dose-escalation study. Lancet. 2016 Dec 17;388(10063):3017-26.
56. Corey DR. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nature neu-
roscience. 2017 Apr;20(4):497-9.
57. Mercuri E, Darras BT, Chiriboga CA, et al. Nusinersen versus Sham Control in Later-Onset Spinal
Muscular Atrophy. The New England journal of medicine. 2018 Feb 15;378(7):625-35.
58. Chiriboga CA, Swoboda KJ, Darras BT, et al. Results from a phase 1 study of nusinersen (ISIS-
SMN(Rx)) in children with spinal muscular atrophy. Neurology. 2016 Mar 8;86(10):890-7.
59. Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer
and other diseases. Nature reviews Drug discovery. 2017 Mar;16(3):203-22.
60. Tao H, Zhao J, Liu T, et al. Intranasal Delivery of miR-146a Mimics Delayed Seizure Onset in the
Lithium-Pilocarpine Mouse Model. Mediators of inflammation. 2017;2017:6512620.
61. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. The
New England journal of medicine. 2013 May 2;368(18):1685-94.
62. Bouchie A. First microRNA mimic enters clinic. Nature biotechnology. 2013 Jul;31(7):577.
63. Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and func-
tion. Trends in biochemical sciences. 2012 Nov;37(11):460-5.
64. Blandford SN, Galloway DA, Moore CS. The roles of extracellular vesicle microRNAs in the central
nervous system. Glia. 2018;[Epub ahead of print].
65. Prada I, Gabrielli M, Turola E, et al. Glia-to-neuron transfer of miRNAs via extracellular vesicles: a
new mechanism underlying inflammation-induced synaptic alterations. Acta neuropathologica.
2018 Apr;135(4):529-50.
66. Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular com-
munication. Trends Cell Biol. 2012 Mar;22(3):125-32.
67. Jin XF, Wu N, Wang L, Li J. Circulating microRNAs: a novel class of potential biomarkers for diag-
nosing and prognosing central nervous system diseases. Cellular and molecular neurobiology.
2013 Jul;33(5):601-13.
68. Wang J, Yu JT, Tan L, et al. Genome-wide circulating microRNA expression profiling indicates bio-
markers for epilepsy. Scientific reports. 2015;5:9522.
69. Liu DZ, Tian Y, Ander BP, et al. Brain and blood microRNA expression profiling of ischemic stroke,
intracerebral hemorrhage, and kainate seizures. Journal of cerebral blood flow and metabo- lism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2010 Jan;30(1):92-101.
70. Roncon P, Soukupova M, Binaschi A, et al. MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples.
DISCUSSION
185
seven